Binex - Paving the Way for Next-Gen Biotech Breakthrough
We met with Mr. HJ Lee, CEO & President of Binex, followed by a quick site tour in Incheon, Korea, and learned that the company has recently...
331 Views
Wuxi Biologics Placement - In Time for the Next Lock-Up, Returns Will Probably Not Match Prior Ones
WuXi Biologics (Cayman) Inc. (2269 HK) plans to raise around US$600m through a mix of primary (85%) and secondary (15%) offering. This will be the...
306 Views
Celltrion & Celltrion Healthcare Placement - Spread Should Narrow as Inclusion Draws Closer
Ion Investment (Temasek) is looking to sell its stake in 2.24m and 2.9m shares in Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS)...
283 Views
The Two Weeks in NorthAsia@Smartkarma That Were: BOJ/N225, Buybacks, & Biosimilars
The past two weeks involved a long Chinese New Year holiday for many so last weekend's Week That Was was carried over. The "slow" two week period...
183 Views
Biosimilar Battlefield: An Update
Korea's biosimilar plays, Celltrion Inc (068270 KS) , Celltrion Pharm Inc (068760 KS) , Celltrion Healthcare (091990 KS) , and Samsung Biologics...
423 Views